Literature DB >> 25149665

Isobolographic analysis of the mechanisms of action of anticonvulsants from a combination effect.

Nobuko Matsumura1, Toshio Nakaki2.   

Abstract

The nature of the pharmacodynamic interactions of drugs is influenced by the drugs׳ mechanisms of action. It has been hypothesized that drugs with different mechanisms are likely to interact synergistically, whereas those with similar mechanisms seem to produce additive interactions. In this review, we describe an extensive investigation of the published literature on drug combinations of anticonvulsants, the nature of the interaction of which has been evaluated by type I and II isobolographic analyses and the subthreshold method. The molecular targets of antiepileptic drugs (AEDs) include Na(+) and Ca(2+) channels, GABA type-A receptor, and glutamate receptors such as NMDA and AMPA/kainate receptors. The results of this review indicate that the nature of interactions evaluated by type I isobolographic analyses but not by the two other methods seems to be consistent with the above hypothesis. Type I isobolographic analyses may be used not only for evaluating drug combinations but also for predicting the targets of new drugs.
Copyright © 2014 Elsevier B.V. All rights reserved.

Keywords:  2-aminophosphonovaleric acid (PubChem CID: 135342); Amlodipine (PubChem CID: 2162); Animal model; Anticonvulsant; CGP 37849 (PubChem CID: 5950212); CGP 39551 (PubChem CID: 6372334); Carbamazepine (PubChem CID: 2554); Clonazepam (PubChem CID: 2802); D cycloserine (PubChem CID: 6234); D-CPP-ene (PubChem CID: 6435801); Diazepam (PubChem CID: 3016); Dizocilpine (PubChem CID: 180081); Drug combinations; Ethosuximide (PubChem CID: 3291); Etomidate (PubChem CID: 36339); Felbamate (PubChem CID: 3331); Gabapentin (PubChem CID: 3446); Glutamate diethyl ester (PubChem CID: 73961); Ifenprodil (PubChem CID: 3689); Ketamine (PubChem CID: 3821); LY233053 (PubChem CID: 15928273); LY235959 (PubChem CID: 131938); LY354740 (PubChem CID: 213056); Lamotrigine (PubChem CID: 3878); Levetiracetam (PubChem CID: 5284583); Loreclezole (PubChem CID: 3034012); Losigamone (PubChem CID: 6918049); MeTHIQ (PubChem CID: 92214); Memantine (PubChem CID: 4054); Muscimol (PubChem CID: 4266); NBQX (PubChem CID: 3272524); Oxcarbazepine (PubChem CID: 34312); Phenobarbital (PubChem CID: 4763); Phenytoin (PubChem CID: 1775); Pregabalin (PubChem CID: 5486971); Procyclidine (PubChem CID: 4919); Propofol (PubChem CID: 4943); Retigabine (PubChem CID: 121892); Riluzole (PubChem CID: 5070); SIB 1893 (PubChem CID: 5311432); Stiripentol (PubChem CID: 5311454); Subthreshold method; Talampanel (PubChem CID: 164509); Tiagabine (PubChem CID: 60648); Topiramate (PubChem CID: 5284627); Trihexyphenidyl (PubChem CID: 5572); Type I isobolographic analysis; Type II isobolographic analysis; Valproate (PubChem CID: 3121); Vigabatrin (PubChem CID: 5665); Zonisamide (PubChem CID: 5734); α-Aminoadipic acid (PubChem CID: 469); γ-Hydroxybutyric acid (PubChem CID: 10413)

Mesh:

Substances:

Year:  2014        PMID: 25149665     DOI: 10.1016/j.ejphar.2014.08.001

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

1.  Seeking the Rational (or at least avoiding the irrational).

Authors:  Barry E Gidal
Journal:  Epilepsy Curr       Date:  2015 Sep-Oct       Impact factor: 7.500

2.  Ketamine could aggravate central nervous toxicity of lidocaine in rats convulsive model.

Authors:  Xiaomei Chen; Ning Wang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  Increased Antiseizure Effectiveness with Tiagabine Combined with Sodium Channel Antagonists in Mice Exposed to Hyperbaric Oxygen.

Authors:  Ivan T Demchenko; Sergei Yu Zhilyaev; Olga S Alekseeva; Alexander I Krivchenko; Claude A Piantadosi; Heath G Gasier
Journal:  Neurotox Res       Date:  2019-05-30       Impact factor: 3.911

4.  Topiramate as an Adjunct in the Management of West Syndrome.

Authors:  Pallavi L Nadig; Jitendra Kumar Sahu; Renu Suthar; Arushi Saini; Naveen Sankhyan
Journal:  Indian J Pediatr       Date:  2019-11-13       Impact factor: 1.967

Review 5.  Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse.

Authors:  C E Van Skike; S E Maggio; A R Reynolds; E M Casey; M T Bardo; L P Dwoskin; M A Prendergast; K Nixon
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-11-12       Impact factor: 5.067

6.  A case of gait disturbance caused by low-dose gabapentin.

Authors:  Megumi Kanao-Kanda; Hirotsugu Kanda; Osamu Takahata; Takayuki Kunisawa
Journal:  Ther Clin Risk Manag       Date:  2016-06-09       Impact factor: 2.423

7.  Anti-Epileptic Drug Combination Efficacy in an In Vitro Seizure Model - Phenytoin and Valproate, Lamotrigine and Valproate.

Authors:  Kim Det Taing; Terence J O'Brien; David A Williams; Chris R French
Journal:  PLoS One       Date:  2017-01-11       Impact factor: 3.240

8.  Polygonogram and isobolographic analysis of interactions between various novel antiepileptic drugs in the 6-Hz corneal stimulation-induced seizure model in mice.

Authors:  Jarogniew J Luszczki; Anna Panasiuk; Mirosław Zagaja; Sławomir Karwan; Hubert Bojar; Zbigniew Plewa; Magdalena Florek-Łuszczki
Journal:  PLoS One       Date:  2020-06-01       Impact factor: 3.240

Review 9.  Isobologram Analysis: A Comprehensive Review of Methodology and Current Research.

Authors:  Ruo-Yue Huang; Linlin Pei; QuanJin Liu; Shiqi Chen; Haibo Dou; Gang Shu; Zhi-Xiang Yuan; Juchun Lin; Guangneng Peng; Wei Zhang; Hualin Fu
Journal:  Front Pharmacol       Date:  2019-10-29       Impact factor: 5.810

10.  Interaction of Analgesic Effects of Dezocine and Sufentanil for Relief of Postoperative Pain: A Pilot Study.

Authors:  He Zhu; Yaobing Chen; Shaoqiang Huang; Xingfeng Sun
Journal:  Drug Des Devel Ther       Date:  2020-11-03       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.